Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia.

Authors:
Zhou W; Yu J; Li Y; Wang K.

Journal:
Exp Hematol Oncol

Publication Year: 2022

DOI:
10.1186/s40164-022-00353-3

PMCID:
PMC9667632

PMID:
36384590

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabil…
Zhou W; Li S; Wang H and 8 more (2024) - Transparency Score: 4/6
Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive …
Shen XT; Xie SZ; Zheng X and 17 more (2024) - Transparency Score: 4/6
Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting c…
Zhao Q; Zong H; Zhu P and 4 more (2024) - Transparency Score: 3/6
Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, …
Liu J; Jiang P; Lu Z and 2 more (2024) - Transparency Score: 3/6
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice.
Zhou L; Lu Y; Liu W and 7 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Competing interestsAll other authors declare no competing interests. Competing interests All other authors declare no competing interests."

Evidence found in paper:

"Funding This study is supported by the National Natural Science Foundation of China (81890994), the National Key R&D Program of China (2019YFA0905902), the Guangdong Basic and Applied Basic Research Foundation (2019A1515010299), the Guangzhou Science and Technology Plan Project (202102020727), the Innovative Research Team of High-level Local Universities in Shanghai, and the Dean' fund of Zhujiang Hospital, Southern Medical University (yzjj2019qn05)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025